Combination treatment of tamoxifen with risperidone in breast cancer.
Tamoxifen has long been used and still is the most commonly used endocrine therapy for treatment of both early and advanced estrogen receptor-positive breast cancer in pre- and post-menopause women. Tamoxifen exerts its cytotoxic effect primarily through cytostasis which is associated with the accum...
Enregistré dans:
Auteurs principaux: | Wei-Lan Yeh, Hui-Yi Lin, Hung-Ming Wu, Dar-Ren Chen |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/34c75769992945b38a66644ca816fce3 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Disruption of the ER-α36-EGFR/HER2 positive regulatory loops restores tamoxifen sensitivity in tamoxifen resistance breast cancer cells.
par: Li Yin, et autres
Publié: (2014) -
Tamoxifen for women at high risk of breast cancer
par: Nazarali SA, et autres
Publié: (2014) -
Preparation and characterization of Tamoxifen citrate loaded nanoparticles for breast cancer therapy
par: Maji R, et autres
Publié: (2014) -
Breast Cancer and Tamoxifen: A Nigerian Perspective to Effective Personalised Therapy
par: Adehin A, et autres
Publié: (2020) -
Combination treatment with risperidone long-acting injection and psychoeducational approaches for preventing relapse in schizophrenia
par: Zhao Y, et autres
Publié: (2013)